Colaboracion Evita — HPV and cervical cancer prevention for women living with HIV
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center
Trying HPV vaccine dose strategies and simpler, low-cost screening and treatment approaches to prevent cervical cancer in women living with HIV in Peru and the Dominican Republic.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11400888 on NIH RePORTER |
What this research studies
You would be part of a multi-site effort that runs three clinical trials focused on preventing cervical cancer among women with HIV. The work combines vaccine dose comparisons with more practical screening and treatment methods that fit into HIV care clinics and require fewer visits and less specialized training. Two clinical sites in Peru and the Dominican Republic will enroll participants, while coordinating, data management, and lab testing are managed through cores in Seattle. The goal is practical, scalable approaches that can be used in low- and middle-income settings to reduce cervical cancer burden.
Who could benefit from this research
Good fit: Women living with HIV in Peru or the Dominican Republic who are eligible for HPV vaccination or cervical cancer screening and treatment would be the ideal candidates.
Not a fit: People who are not women living with HIV, those already treated for invasive cervical cancer, or individuals outside the study countries are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, this could lower cervical cancer rates and simplify prevention and care for women living with HIV in low-resource settings.
How similar studies have performed: HPV vaccines work well in the general population and some data support benefit in people with HIV, but optimal dose schedules and simplified screening/treatment models for low-resource settings remain under study.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Madeleine, Margaret M — Fred Hutchinson Cancer Center
- Study coordinator: Madeleine, Margaret M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.